Investigating the harmful effects of flavor chemicals in electronic cigarettes
Characterization of Potential Harm Caused by Electronic Cigarette Flavor Chemicals and their Reaction Products
This study is looking at how the flavor chemicals in e-cigarettes might affect lung cells, so we can better understand their safety and health risks for people who use them.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Riverside NIH-funded |
| Lab location | 1 site (Riverside, United States) |
| Project ID | NIH-10438598 on NIH RePORTER |
What this research studies
This research focuses on understanding the potential harm caused by flavor chemicals found in electronic cigarettes (e-cigarettes) and their breakdown products when vaporized. The project involves analyzing 650 different e-liquids to identify and quantify these chemicals and their effects on human cells. Researchers will conduct experiments to assess how these flavor chemicals and aerosols impact lung cells, using advanced techniques like gas chromatography and mass spectrometry. The study aims to provide insights into the safety of e-cigarette flavors and their health implications.
Who could benefit from this research
Good fit: Ideal candidates for this research include adult e-cigarette users who are concerned about the health effects of flavored e-liquids.
Not a fit: Patients who do not use e-cigarettes or are under 21 years old may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better regulations and safer e-cigarette products, ultimately protecting public health.
How similar studies have performed: Previous research has shown that flavor chemicals in e-cigarettes can have harmful effects, indicating that this study builds on existing knowledge rather than being entirely novel.
Where this research is happening
Riverside, United States
- University of California Riverside — Riverside, United States (Active)
Researchers
- Principal investigator: Talbot, Prudence — University of California Riverside
- Study coordinator: Talbot, Prudence
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.